The Biological Activity of Designer Drugs from the Group of Synthetic Opioids

被引：0
|
作者：
A. I. Golovko
Ju. Ju. Ivnitsky
M. B. Ivanov
V. L. Rejniuk
V. K. Kozlov
机构：
[1] Institute of Toxicology of Federal Medicobiological Agency of Russia,
来源：
Biology Bulletin Reviews | 2021年 / 11卷 / 2期
关键词：
designer synthetic opioids; biological activity; µ-opioid receptors; affinity; agonistic properties;
D O I：
10.1134/S2079086421020031
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 197
页数：11
相关论文
共 50 条
  • [31] Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of "Nitazene" 2-Benzylbenzimidazole Synthetic Opioids
    Vandeputte, Marthe M.
    Van Uytfanghe, Katleen
    Layle, Nathan K.
    St Germaine, Danielle M.
    Iula, Donna M.
    Stove, Christophe P.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (07): : 1241 - 1251
  • [32] Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review
    Akira Namera
    Akihiro Nakamoto
    Takeshi Saito
    Masataka Nagao
    Forensic Toxicology, 2011, 29 : 1 - 24
  • [33] Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review
    Namera, Akira
    Nakamoto, Akihiro
    Saito, Takeshi
    Nagao, Masataka
    FORENSIC TOXICOLOGY, 2011, 29 (01) : 1 - 24
  • [34] A RADIORECEPTOR ASSAY TO DETECT FENTANYL-LIKE DESIGNER DRUGS IN BIOLOGICAL SPECIMENS
    ROLLINS, DE
    ALBURGES, ME
    HANSON, GR
    GIBB, JW
    SAKASHITA, CO
    VETERINARY AND HUMAN TOXICOLOGY, 1988, 30 (04) : 367 - 367
  • [35] What If Your Designer is from a Minority Group?
    Gichuhi, Evelyn Wangui
    MEDIALISIERUNGEN AFRIKAS, 2018, 4 : 155 - 170
  • [36] Veterinary anaesthesia and analgesia: from chloroform to designer drugs
    Taylor, Polly
    VETERINARY RECORD, 2014, 174 (13) : 318 - 321
  • [37] Primary hyperoxaluria: from gene defects to designer drugs?
    Danpure, CJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (08) : 1525 - 1529
  • [38] Detection and Quantification of New Designer Drugs in Human Blood: Part 1 Synthetic Cannabinoids
    Ammann, Julia
    McLaren, Jenna M.
    Gerostamoulos, Dimitri
    Beyer, Jochen
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2012, 36 (06) : 372 - 380
  • [39] DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs
    Ogata, Jun
    Uchiyama, Nahoko
    Kikura-Hanajiri, Ruri
    Goda, Yukihiro
    FORENSIC SCIENCE INTERNATIONAL, 2013, 227 (1-3) : 33 - 41
  • [40] BIOLOGICAL-ACTIVITY OF SYNTHETIC GLYCEROPHOSPHOLIPIDS
    KLUGE, S
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1988, 65 (04) : 481 - 481
12345